Today’s top gainers include the company Perrigo Company plc (NYSE:PRGO) which is in the industry Drug Related Products, gaining 0.34% today. In the last week its performance is 0.82%, and 0.03% for the past quarter. Currently, Perrigo Company plc, PRGO has a target price of 102.64, so today’s gain of 0.34% is a significant step towards its target price. The GAP today is therefore -0.55%.
Perrigo Company plc (NYSE:PRGO), has a market cap of 13517.59, and is based in Ireland. Insider ownership is at 0.10%, and institutional ownership is 75.10%.
At the current price of 93.69, it has a dividend yield of 0.62%, and its target price is 102.64. This is with a profit margin of -2.40%, and total debt/equity of 0.65. Perrigo Company plc (NYSE:PRGO) has a P/E of *TBA, as well as a forward P/E of 12.05.
With a current EPS of -0.95, and a forecasted EPS growth for next year at 10.16%,Perrigo Company plc (NYSE:PRGO) has had a EPS growth for the past five years at -59.80%. For the next five years EPS growth is projected to be 7.98%.
Performance for the year is -45.24%. Since its IPO date on 12/17/1991, the total performance to date is -34.98%.
Volume today for Perrigo Company plc (NYSE:PRGO), is 1570200, while its average volume is 2217.73. Whilst the total gain today was 0.34%, it did have a day high of -3.55%.
Volatility for this week has been at 1.97%, and 2.53% for the month. The 52-week low for Perrigo Company plc, PRGO has been 13.74%, while the 52-week-high has reached -47.27%.
Looking at its return of investments, which is 0.60%, and its return on assets is -0.70%. Perrigo Company plc (NYSE:PRGO) has an operating margin of 0.50%. With a sales growth of -3.30% quarter over quarter. Bearing in mind that Perrigo Company plc, PRGO is in the sector Healthcare, its long-term debt/equity is 0.57, and has a current ratio of 1.4 and 1 for quick ratio.
So what is the value of Perrigo Company plc? Well its PEG is *TBA, and the P/S is 2.4, along with a P/B of 1.36. Meanwhile it has a p/cash of *TBA.